The relationship between personality and post traumatic stress disorder
European Psychiatry May 1, 2002 Farāmarz Sohrābi
A 31-year-old male military veteran with moderate alcohol use disorder received sequential treatment with ibogaine hydrochloride (1550 mg, 17.9 mg/kg) followed by vaporized 5-MeO-DMT (bufotoxin source 50 mg, estimated 5-MeO-DMT content 5–7 mg) at an inpatient clinic in Mexico. SPECT neuroimaging before and 3 days after the program showed increased brain perfusion in bilateral caudate nuclei, left putamen, right insula, and temporal, occipital, and cerebellar regions. The patient reported improved mood, cessation of alcohol use, and reduced cravings at 5 days, sustained at 1 month, with a partial return to mild alcohol use at 2 months. The findings suggest short-term therapeutic outcomes and warrant further investigation.